Evidence map›Paper›PMID 42505612›Full record

ReviewAntibiotics (Basel, Switzerland)2026

Antimicrobial Peptides, Bacteriocins and Mycocins as Natural Antimicrobials: Applications in Food Safety, Agriculture and Healthcare.

Patrícia Branco, Elisabete Muchagato Maurício, Luís R Raposo, Catarina Roma-Rodrigues

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patrícia BrancoBIORG-Bioengineering and Sustainability Research Group, Lusófona University, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-1760-6899
Elisabete Muchagato MaurícioBIORG-Bioengineering and Sustainability Research Group, Lusófona University, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-3959-2993
Luís R RaposoBIORG-Bioengineering and Sustainability Research Group, Lusófona University, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-8637-346X
Catarina Roma-RodriguesBIORG-Bioengineering and Sustainability Research Group, Lusófona University, Av. Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-8676-6562

Funding

Universidade Lusófona https://doi.org/10.62658/COFAC/ILIND/BIORG/2/2025
6 · The paper itself

Abstract

The growing concern over antimicrobial resistance and the increasing demand for safer and more sustainable antimicrobial strategies have driven extensive research into peptide-based natural antimicrobials. This review focuses specifically on antimicrobial peptides (AMPs), bacteriocins and mycocins as peptide- or proteinaceous antimicrobial compounds with potential applications as active ingredients, biopreservatives and antimicrobial tools. These compounds exhibit activity against spoilage and pathogenic microorganisms and are increasingly being explored in food safety, agriculture, cosmetics, animal health and human healthcare. AMPs, bacteriocins and mycocins act through diverse and sometimes overlapping mechanisms, including membrane disruption, pore formation, inhibition of cell wall biosynthesis, interference with intracellular targets, induction of oxidative stress and modulation of host or microbial responses. These mechanisms support their potential use in food biopreservation, crop protection, biofungicide and biopesticide development, topical antimicrobial formulations, cosmetic preservation, antibiofilm strategies and adjunctive therapeutic approaches. Recent advances in encapsulation, peptide engineering, recombinant production, nanodelivery and combination strategies with conventional antibiotics, hurdle technologies or other natural antimicrobials have improved the stability, bioavailability and antimicrobial efficacy of these compounds in experimental systems. However, broader translation remains limited by several major challenges. These include proteolytic degradation, reduced stability in complex matrices, context-dependent antimicrobial activity, possible toxicity, resistance development, high production and purification costs, formulation difficulties, scale-up limitations and regulatory constraints. Further validation is also needed regarding safety, microbiome impact, environmental fate and performance under realistic food-preservation, agricultural, cosmetic and clinical conditions. This review summarises and compares the diversity, mechanisms, applications and translational challenges of AMPs, bacteriocins and mycocins across food safety, sustainable agriculture, cosmetics, animal health and healthcare. It also discusses the main challenges that must be addressed before broader translation, including resistance risk, stability, formulation, scale-up, safety assessment and regulatory approval.

Indexed as

antimicrobial peptidesbacteriocinsbiofungicidesbiopesticidesbiopreservationfood safetymicrobial natural productsmycocinspeptide-based compounds

Identifiers

PMID42505612
PMCPMC13403446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.